Anti-Tumor Agent and Immunostimulating Agent

To provide a pharmaceutical composition comprising a ceramide-related substance having little adverse side effects as an active ingredient by using a raw material that is highly safe to a human body and is inexpensive. A pharmaceutical composition comprising at least one sphingoglycolipid derivative...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: IWASAKI HIRONORI, TAKEUCHI KOUJI, MATSUZAKI GORO, WATANABE HISAMI, TAKARA KENSAKU, TAIRA AKIRA, ISHIKAWA TAKAHIRO, OKU HIROSUKE
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator IWASAKI HIRONORI
TAKEUCHI KOUJI
MATSUZAKI GORO
WATANABE HISAMI
TAKARA KENSAKU
TAIRA AKIRA
ISHIKAWA TAKAHIRO
OKU HIROSUKE
description To provide a pharmaceutical composition comprising a ceramide-related substance having little adverse side effects as an active ingredient by using a raw material that is highly safe to a human body and is inexpensive. A pharmaceutical composition comprising at least one sphingoglycolipid derivative that is produced from a beer waste and is represented by the formula below as an active ingredient: wherein R3 represents H or OH; R4 is as defined by (a) or (b): (a) when R3 is H, R4 represents (CH2)13CH3 or (CH2)6CH CHCH2CH CH(CH2)4CH3; and (b) when R3 is OH, R4 represents (CH2)yCH3 (where Y represents an integer of 13 to 21) or (CH2)z1CH CH(CH2)Z2CH3 (where Z1 and Z2 independently represent 0 or a natural number, provided that Z1+Z2=19).
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2010256346A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2010256346A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2010256346A13</originalsourceid><addsrcrecordid>eNrjZNBxzCvJ1A0pzc0vUnBMT80rUUjMS1HwzM0tzcsvLsnMLc1JLMnMS4fI8TCwpiXmFKfyQmluBmU31xBnD93Ugvz41OKCxOTUvNSS-NBgIwNDAyNTM2MTM0dDY-JUAQAg8SqI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Anti-Tumor Agent and Immunostimulating Agent</title><source>esp@cenet</source><creator>IWASAKI HIRONORI ; TAKEUCHI KOUJI ; MATSUZAKI GORO ; WATANABE HISAMI ; TAKARA KENSAKU ; TAIRA AKIRA ; ISHIKAWA TAKAHIRO ; OKU HIROSUKE</creator><creatorcontrib>IWASAKI HIRONORI ; TAKEUCHI KOUJI ; MATSUZAKI GORO ; WATANABE HISAMI ; TAKARA KENSAKU ; TAIRA AKIRA ; ISHIKAWA TAKAHIRO ; OKU HIROSUKE</creatorcontrib><description>To provide a pharmaceutical composition comprising a ceramide-related substance having little adverse side effects as an active ingredient by using a raw material that is highly safe to a human body and is inexpensive. A pharmaceutical composition comprising at least one sphingoglycolipid derivative that is produced from a beer waste and is represented by the formula below as an active ingredient: wherein R3 represents H or OH; R4 is as defined by (a) or (b): (a) when R3 is H, R4 represents (CH2)13CH3 or (CH2)6CH CHCH2CH CH(CH2)4CH3; and (b) when R3 is OH, R4 represents (CH2)yCH3 (where Y represents an integer of 13 to 21) or (CH2)z1CH CH(CH2)Z2CH3 (where Z1 and Z2 independently represent 0 or a natural number, provided that Z1+Z2=19).</description><language>eng</language><subject>CHEMISTRY ; DERIVATIVES THEREOF ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; SUGARS</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20101007&amp;DB=EPODOC&amp;CC=US&amp;NR=2010256346A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25544,76295</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20101007&amp;DB=EPODOC&amp;CC=US&amp;NR=2010256346A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>IWASAKI HIRONORI</creatorcontrib><creatorcontrib>TAKEUCHI KOUJI</creatorcontrib><creatorcontrib>MATSUZAKI GORO</creatorcontrib><creatorcontrib>WATANABE HISAMI</creatorcontrib><creatorcontrib>TAKARA KENSAKU</creatorcontrib><creatorcontrib>TAIRA AKIRA</creatorcontrib><creatorcontrib>ISHIKAWA TAKAHIRO</creatorcontrib><creatorcontrib>OKU HIROSUKE</creatorcontrib><title>Anti-Tumor Agent and Immunostimulating Agent</title><description>To provide a pharmaceutical composition comprising a ceramide-related substance having little adverse side effects as an active ingredient by using a raw material that is highly safe to a human body and is inexpensive. A pharmaceutical composition comprising at least one sphingoglycolipid derivative that is produced from a beer waste and is represented by the formula below as an active ingredient: wherein R3 represents H or OH; R4 is as defined by (a) or (b): (a) when R3 is H, R4 represents (CH2)13CH3 or (CH2)6CH CHCH2CH CH(CH2)4CH3; and (b) when R3 is OH, R4 represents (CH2)yCH3 (where Y represents an integer of 13 to 21) or (CH2)z1CH CH(CH2)Z2CH3 (where Z1 and Z2 independently represent 0 or a natural number, provided that Z1+Z2=19).</description><subject>CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>SUGARS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNBxzCvJ1A0pzc0vUnBMT80rUUjMS1HwzM0tzcsvLsnMLc1JLMnMS4fI8TCwpiXmFKfyQmluBmU31xBnD93Ugvz41OKCxOTUvNSS-NBgIwNDAyNTM2MTM0dDY-JUAQAg8SqI</recordid><startdate>20101007</startdate><enddate>20101007</enddate><creator>IWASAKI HIRONORI</creator><creator>TAKEUCHI KOUJI</creator><creator>MATSUZAKI GORO</creator><creator>WATANABE HISAMI</creator><creator>TAKARA KENSAKU</creator><creator>TAIRA AKIRA</creator><creator>ISHIKAWA TAKAHIRO</creator><creator>OKU HIROSUKE</creator><scope>EVB</scope></search><sort><creationdate>20101007</creationdate><title>Anti-Tumor Agent and Immunostimulating Agent</title><author>IWASAKI HIRONORI ; TAKEUCHI KOUJI ; MATSUZAKI GORO ; WATANABE HISAMI ; TAKARA KENSAKU ; TAIRA AKIRA ; ISHIKAWA TAKAHIRO ; OKU HIROSUKE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2010256346A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2010</creationdate><topic>CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>SUGARS</topic><toplevel>online_resources</toplevel><creatorcontrib>IWASAKI HIRONORI</creatorcontrib><creatorcontrib>TAKEUCHI KOUJI</creatorcontrib><creatorcontrib>MATSUZAKI GORO</creatorcontrib><creatorcontrib>WATANABE HISAMI</creatorcontrib><creatorcontrib>TAKARA KENSAKU</creatorcontrib><creatorcontrib>TAIRA AKIRA</creatorcontrib><creatorcontrib>ISHIKAWA TAKAHIRO</creatorcontrib><creatorcontrib>OKU HIROSUKE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>IWASAKI HIRONORI</au><au>TAKEUCHI KOUJI</au><au>MATSUZAKI GORO</au><au>WATANABE HISAMI</au><au>TAKARA KENSAKU</au><au>TAIRA AKIRA</au><au>ISHIKAWA TAKAHIRO</au><au>OKU HIROSUKE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Anti-Tumor Agent and Immunostimulating Agent</title><date>2010-10-07</date><risdate>2010</risdate><abstract>To provide a pharmaceutical composition comprising a ceramide-related substance having little adverse side effects as an active ingredient by using a raw material that is highly safe to a human body and is inexpensive. A pharmaceutical composition comprising at least one sphingoglycolipid derivative that is produced from a beer waste and is represented by the formula below as an active ingredient: wherein R3 represents H or OH; R4 is as defined by (a) or (b): (a) when R3 is H, R4 represents (CH2)13CH3 or (CH2)6CH CHCH2CH CH(CH2)4CH3; and (b) when R3 is OH, R4 represents (CH2)yCH3 (where Y represents an integer of 13 to 21) or (CH2)z1CH CH(CH2)Z2CH3 (where Z1 and Z2 independently represent 0 or a natural number, provided that Z1+Z2=19).</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2010256346A1
source esp@cenet
subjects CHEMISTRY
DERIVATIVES THEREOF
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
SUGARS
title Anti-Tumor Agent and Immunostimulating Agent
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T09%3A49%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=IWASAKI%20HIRONORI&rft.date=2010-10-07&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2010256346A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true